Page last updated: 2024-09-03

sc 58125 and Diabetic Nephropathies

sc 58125 has been researched along with Diabetic Nephropathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kajiyama, S; Kawamoto, M; Kurita, S; Matsunaga, A; Shiraishi, S; Yasuda, T; Yuge, O	1

Other Studies

1 other study(ies) available for sc 58125 and Diabetic Nephropathies

Article	Year
Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats. European journal of pharmacology, 2007, Jan-05, Volume: 554, Issue:1 Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dinoprostone; Hyperalgesia; Injections, Spinal; Male; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Streptozocin	2007

Article

Year

Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats.

European journal of pharmacology, 2007, Jan-05, Volume: 554, Issue:1

Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dinoprostone; Hyperalgesia; Injections, Spinal; Male; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Streptozocin

2007